KBC Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Sell |
2,930
-1,354
| -32% | -$36K | ﹤0.01% | 1370 |
|
|
2025
Q1 | $103K | Buy |
4,284
+30
| +0.7% | +$721 | ﹤0.01% | 1469 |
|
|
2024
Q4 | $171K | Buy |
4,254
+1,257
| +42% | +$50.5K | ﹤0.01% | 1219 |
|
|
2024
Q3 | $190K | Buy |
2,997
+473
| +19% | +$30K | ﹤0.01% | 958 |
|
|
2024
Q2 | $134K | Buy |
2,524
+736
| +41% | +$39.1K | ﹤0.01% | 1026 |
|
|
2024
Q1 | $147K | Buy |
+1,788
| New | +$147K | ﹤0.01% | 949 |
|
|
2023
Q4 | – | Sell |
-1,445
| Closed | -$16K | – | 1909 |
|
|
2023
Q3 | $16K | Buy |
+1,445
| New | +$16K | ﹤0.01% | 1905 |
|